<DOC>
	<DOCNO>NCT00979368</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability pharmacokinetics follow single oral dos BMS-816336 healthy male subject .</brief_summary>
	<brief_title>Safety Study BMS-816336 Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Healthy male subject BMI 18 32 kg/m² Men , age 1855 year Sexually active men use effective birth control partner WOCBP Any significant acute chronic medical illness Family history Gilbert 's disease History Pancreatitis Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , EGG clinical laboratory determination QTc interval &gt; 450 msec ( correct heart rate use Fridericia 's correction method , QTcF ) Second thirddegree AV block clinically relevant ECG abnormality History allergy 11βHSD1 inhibitor related compound Prior exposure BMS816336 Use St. John 's Wort ( Hypericum ) within 4 week prior first dose study drug throughout study Use oral , injectable , inhalable suspension glucocorticoid agent within 12 week study drug administration Use glucocorticoid topical cream within 4 week study drug administration Use oral , injectable , topical androgen agent within 12 week prior enrollment</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>